Skip to main content
Article thumbnail
Location of Repository


By Kieran MW


Mark KieranDana-Farber Cancer Institute, Boston, MA, USARapid advances in the molecular characterization of cancer have resulted in new approaches to treatment. For greatest impact, targeted agents, in combination with traditional therapies, will need to be tested in each age group and for each disease. Adolescents and young adults are being recognized as a distinct group of patients that unfortunately are under-represented in formal clinical trials and new treatment assessments. The reason for this are multiple and include the lack of insurance coverage for many as they transition to independence from their parents, the sense of invincibility that many young adults feel, the types of tumors observed in these patients, and the lack of coordinated clinical trial consortiums for this age group

Topics: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Internal medicine, RC31-1245, Medicine, R, DOAJ:Oncology, DOAJ:Medicine (General), DOAJ:Health Sciences
Publisher: Dove Medical Press
Year: 2011
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.